It has been reported that the decreased insulin levels and impaired insulin signaling in the brain of AD patients could lead to the dysfunctions of glucose metabolism and synaptic plasticity, and the formation of NFTs and amyloid plaques, which are the critical processes involved in AD progression (Rad et al., 2018; Chen et al., 2023). The gene discussed is INS; the disease is Alzheimer disease.